FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Imprimis NJOF Dexamethasone Recall

Dexamethasone - Moxifloxacin PF Injection (1/5) mg/mL, Imprimis Rx Volume: 1mL/vial, Im…

Imprimis NJOF, LLC · Ledgewood, NJ

Risk level
Class II
Reported by FDA
Jan 6, 2021
Recall ID
D-0177-2021
Check your lot numberHow we source this data

Summary

Imprimis NJOF recalled Dexamethasone starting Dec 17, 2020. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0177-2021 on Jan 6, 2021. Reason: Lack of assurance of sterility: 13 vials were discovered to have faulty crimps. Status: Terminated.

Why it was recalled

Lack of assurance of sterility: 13 vials were discovered to have faulty crimps.

Product description

Dexamethasone - Moxifloxacin PF Injection (1/5) mg/mL, Imprimis Rx Volume: 1mL/vial, Imprimis NJOF, LLC. 1705 Route 46 West, Unit 6B Ledgewood, NJ - 07852 (844)446-6979

Lot numbers, UPCs & expiration codes

Lot#: 20JUN010, Exp 5/12/21

Where it was sold

U.S.A. Nationwide

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0177-2021
Classification
Class II
Status
Terminated
Recall initiated
Dec 17, 2020
FDA report date
Jan 6, 2021
Quantity
6520 vials
Recall type
Voluntary: Firm initiated
Recalling firm
Imprimis NJOF, LLC

Original FDA data

Every field from FDA enforcement report D-0177-2021, exactly as published.

Show all FDA fields
City
Ledgewood
State
NJ
Status
Terminated
Country
United States
Event ID
87029
Address
1705 Route 46 Ste 6B
Code information
Lot#: 20JUN010, Exp 5/12/21
Postal code
07852-9720
Report date
Jan 6, 2021
Product type
Drugs
Recall number
D-0177-2021
Classification
Class II
Recalling firm
Imprimis NJOF, LLC
Product quantity
6520 vials
Termination date
Aug 23, 2023
Reason for recall
Lack of assurance of sterility: 13 vials were discovered to have faulty crimps.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Dexamethasone - Moxifloxacin PF Injection (1/5) mg/mL, Imprimis Rx Volume: 1mL/vial, Imprimis NJOF, LLC. 1705 Route 46 West, Unit 6B Ledgewood, NJ - 07852 (844)446-6979
Distribution pattern
U.S.A. Nationwide
Recall initiation date
Dec 17, 2020
Initial firm notification
Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit
Center classification date
Dec 30, 2020

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0177-2021, published Jan 6, 2021. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls